Post The Parker Institute for Cancer Immunotherapy Partners with Xyphos Biosciences to Develop Universal Programmable CAR-T Cells for Cancer Treatment
Post An Initiative Led by Parker Institute for Cancer Immunotherapy and Cancer Research Institute Discovers Keys That Could Unlock Better Personalized Treatments to Destroy Cancer
Post Parker Institute for Cancer Immunotherapy Scientists Present at ASCO 2018 on Gene Editing in Cell Therapy, Novel Checkpoint Inhibitor Combinations and Other Advances in Immuno-Oncology